Questions a plan sponsor actually asks.
What is Dapagliflozin used for?
Dapagliflozin is a SGLT2 Inhibitor (Antidiabetic) medication tracked in Medicare Part D.
Is there a generic for Dapagliflozin?
No. Dapagliflozin is brand-only with no generic equivalents currently in market.
How much does my plan pay for Dapagliflozin?
Across 329 Part D plans, Dapagliflozin averages $11.91/unit (NADAC). Lowest available: $11.48/unit. Highest in distribution: $12.08/unit.
Is Dapagliflozin on the FDA shortage list?
No. Dapagliflozin is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (2 approvals on file) · NADAC unit costs: CMS NADAC weekly file (7 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.